ALX Oncology
ALXO
ALXO
96 hedge funds and large institutions have $622M invested in ALX Oncology in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% less funds holding
Funds holding: 108 → 96 (-12)
20% less capital invested
Capital invested by funds: $780M → $622M (-$158M)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
Holders
96
Holding in Top 10
3
Calls
$444K
Puts
$361K
Top Buyers
| 1 | +$16.3M | |
| 2 | +$11.7M | |
| 3 | +$7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.61M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$4.44M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$15.5M | |
| 3 | -$4.09M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.29M |
| 5 |
Millennium Management
New York
|
-$1.82M |